Musculoskeletal
Tendinitis
7
Pipeline Programs↗
3
Active Trials↗
6
Companies Involved↗
Tendinitis is an early-stage landscape with 7 programs across 6 companies. The most active players are Eli Lilly, Taiwan Bio Therapeutics Inc., Alnylam Pharmaceuticals. 4 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 2
No programs
Analysis
Trial Status
7
clinical trials
Completed3 · 43%
Not yet recruiting1 · 14%
Unknown status1 · 14%
Active, not recruiting1 · 14%
Recruiting1 · 14%
Clinical Trials
Trial Activity
7 trials
Effect of Extracorporeal Shock Wave Combined With Autologous Platelet-rich Plasma Injection on Rotator Cuff Calcific Tendinitis
Not yet recruiting·—·N/A·NCT06372600·60 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)